title: Phase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate.
authors: Institut Gustave-Roussy, Villejuif.
authors: J P
authors: JP
authors: Droz
authors: P
authors: P
authors: Fargeot
authors: P
authors: P
authors: Laplaige
authors: A
authors: A
authors: Moran-Ribon
authors: G
authors: G
authors: Piot
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D004317:Doxorubicin; D002945:Cisplatin; D005472:Fluorouracil